
### [NCIT:C96166](http://purl.obolibrary.org/obo/NCIT_C96166)
**Label:** Digestive System Neuroendocrine Tumor G2

**Subclasses:** [NCIT:C96163](http://purl.obolibrary.org/obo/NCIT_C96163) (Colorectal Neuroendocrine Tumor G2), [NCIT:C96165](http://purl.obolibrary.org/obo/NCIT_C96165) (Intestinal Neuroendocrine Tumor G2), [NCIT:C96067](http://purl.obolibrary.org/obo/NCIT_C96067) (Small Intestinal Neuroendocrine Tumor G2), [NCIT:C27466](http://purl.obolibrary.org/obo/NCIT_C27466) (Pancreatic ACTH-Producing Neuroendocrine Tumor), [NCIT:C96423](http://purl.obolibrary.org/obo/NCIT_C96423) (Appendix Neuroendocrine Tumor G2), [NCIT:C95983](http://purl.obolibrary.org/obo/NCIT_C95983) (Ampulla of Vater Neuroendocrine Tumor G2), [NCIT:C45841](http://purl.obolibrary.org/obo/NCIT_C45841) (Functional Pancreatic Neuroendocrine Tumor G2), [NCIT:C95880](http://purl.obolibrary.org/obo/NCIT_C95880) (Gastric Neuroendocrine Tumor G2), [NCIT:C95617](http://purl.obolibrary.org/obo/NCIT_C95617) (Esophageal Neuroendocrine Tumor G2), [NCIT:C45835](http://purl.obolibrary.org/obo/NCIT_C45835) (Pancreatic Neuroendocrine Tumor G2), [NCIT:C67369](http://purl.obolibrary.org/obo/NCIT_C67369) (Malignant Pancreatic Somatostatinoma), [NCIT:C45838](http://purl.obolibrary.org/obo/NCIT_C45838) (Non-Functional Pancreatic Neuroendocrine Tumor G2), [NCIT:C65187](http://purl.obolibrary.org/obo/NCIT_C65187) (Malignant Pancreatic Glucagonoma), [NCIT:C96546](http://purl.obolibrary.org/obo/NCIT_C96546) (Anal Canal Neuroendocrine Tumor G2), [NCIT:C96957](http://purl.obolibrary.org/obo/NCIT_C96957) (Extrahepatic Bile Duct Neuroendocrine Tumor G2), [NCIT:C96925](http://purl.obolibrary.org/obo/NCIT_C96925) (Gallbladder Neuroendocrine Tumor G2), 

**Class expressions from DL-Learner:**

- Thing 53.55%
- [NCIT:C45858](http://purl.obolibrary.org/obo/NCIT_C45858) (Gain of Chromosome 4) 52.63%
- [NCIT:C40557](http://purl.obolibrary.org/obo/NCIT_C40557) (Metastatic Lesion) 52.63%
- [NCIT:C39909](http://purl.obolibrary.org/obo/NCIT_C39909) (Gain of Chromosome 18q) 52.63%
- [NCIT:C36585](http://purl.obolibrary.org/obo/NCIT_C36585) (Loss of Chromosome 10) 52.63%
- [NCIT:C36545](http://purl.obolibrary.org/obo/NCIT_C36545) (Gain of Chromosome 5q) 52.63%
- [NCIT:C36504](http://purl.obolibrary.org/obo/NCIT_C36504) (Loss of Chromosome 6) 52.63%
- [NCIT:C36502](http://purl.obolibrary.org/obo/NCIT_C36502) (Loss of Chromosome 3p) 52.63%
- [NCIT:C36480](http://purl.obolibrary.org/obo/NCIT_C36480) (Gain of Chromosome 20q) 52.63%
- [NCIT:C36454](http://purl.obolibrary.org/obo/NCIT_C36454) (Gain of Chromosome 7) 52.63%
- [NCIT:C36441](http://purl.obolibrary.org/obo/NCIT_C36441) (Gain of Chromosome 12q) 52.63%
- [NCIT:C36141](http://purl.obolibrary.org/obo/NCIT_C36141) (Intermediate Grade Lesion) 52.63%
- [NCIT:C36133](http://purl.obolibrary.org/obo/NCIT_C36133) (Well Differentiated Lesion) 52.63%
- [NCIT:C36132](http://purl.obolibrary.org/obo/NCIT_C36132) (Poorly Differentiated Lesion) 52.63%
- [NCIT:C3426](http://purl.obolibrary.org/obo/NCIT_C3426) (Ulcer) 37.99%


